✦ LIBER ✦

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

✍ Scribed by Anne Katrin Sjølie; Ronald Klein; Massimo Porta; Trevor Orchard; John Fuller; Hans Henrik Parving; Rudy Bilous; Nish Chaturvedi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of candesartan on prevention (DIR

✍ Nish Chaturvedi; Massimo Porta; Ronald Klein; Trevor Orchard; John Fuller; Hans 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 206 KB

Effects of blood pressure lowering and i

✍ J. W. J. Beulens; A. Patel; J. R. Vingerling; J. K. Cruickshank; A. D. Hughes; A 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 186 KB

Study protocol: a randomised placebo-con

✍ Yvonne HM Krul-Poel,Hans van Wijland,Frank Stam… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 666 KB

Exposure to candesartan during the first

✍ M. Porta; J. W. Hainer; S.-O. Jansson; A. Malm; R. Bilous; N. Chaturvedi; J. H. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 121 KB

Effect of Exercise on Blood Pressure in

✍ Dobrosielski, Devon A.; Gibbs, Bethany Barone; Ouyang, Pamela; Bonekamp, Susanne 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Effect of dapagliflozin in patients with

✍ Clifford J Bailey; Jorge L Gross; Anne Pieters; Arnaud Bastien; James F List 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 260 KB